Cancer prevention drug also disables H. pylori bacterium
Researchers have discovered that a medicine currently being tested as a chemoprevention agent for multiple types of cancer also disables Helicobacter pylori... Read More
Updated Clinical Data from Combination of Margetuximab and Pembrolizumab in Gastric Cancer Presented at 2019 ASCO Gastrointestinal Cancers Symposium
“We continue to be very encouraged by the tolerability and antitumor activity of margetuximab with an anti-PD-1 mAb, an investigational, chemotherapy-free approach... Read More
Taiho Oncology and Servier Present Data on LONSURF (trifluridine/tipiracil) at ASCO 2019 Gastrointestinal Cancers Symposium (ASCO GI)
A new study evaluating LONSURF in patients with previously treated metastatic gastric cancer is consistent with the overall study results published in... Read More
Five Prime Therapeutics Presents Data from Safety Lead-in to Phase 3 FIGHT Trial of Bemarituzumab at 2019 American Society of Clinical Oncology (ASCO) Gastrointestinal (GI) Cancers Symposium
“Gastric cancer with FGFR2b overexpression or FGFR2 gene amplification is associated with a poor prognosis for patients with advanced disease,” said Helen... Read More
Safety and efficacy of durvalumab following trimodality therapy for locally advanced esophageal and GEJ adenocarcinoma: Early efficacy results from Big Ten Cancer Research Consortium study
Presented at last week’s ASCO Gastrointestinal Cancers Symposium, noteworthy studies incuded new approaches to treating and managing gastric cancer including the safety... Read More
A phase II, randomised study of mFOLFOX6 with or without the Akt inhibitor ipatasertib in patients with locally advanced or metastatic gastric or gastroesophageal junction cancer
Researchers evaluated the addition of the AKT inhibitor ipatasertib to mFOLFOX6 for patients with gastric cancer.
Citrus fruit intake and gastric cancer: The stomach cancerpooling (StoP) project consortium
A new study in International Journal of Cancer evaluated the link between eating citrus fruit and gastric cancer risk, finding protective effects... Read More
Biotech Imugene ‘encouraged’ by data for HER2 vaccine in gastric cancer
An early stage drug tested in a new study shows promising results for gastric cancer patients.
Association of quality of life with disease characteristics and treatment outcomes in patients with advanced gastric cancer: Exploratory analysis of RAINBOW and REGARD phase III trials
A new study in Oncology Advance looks at the association between quality of life, disease characteristics, and treatment outcomes in patients with... Read More
A Conceptual Overview of Targeted Therapy in GI Cancers
Watch this PracticeUpdate video for an overview of gastric cancer treatments (register for free to view).
